News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tekmira Pharmaceuticals Corporation Announces Presentation of Data Using SNALP RNAi Delivery Technology



10/22/2008 8:31:08 AM

VANCOUVER, BRITISH COLUMBIA--(Marketwire - October 22, 2008) - Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that studies conducted by Tekmira and Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica, N.V. (J&JPRD), have shown that novel small interfering RNA (siRNA) molecules enabled by Tekmira's proprietary SNALP technology significantly reduce fat storage in the liver.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES